Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claes Held

Showing results (51-60 of 227) with videos related to

Pageof 23
Sort By:
European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registryKatarina Mars, John Wallert, Claes Held, et al.
JAMA|April 11, 2023
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical TrialJohan Sundström, Lars Lind, Shamim Nowrouzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 21, 2007
A high-fat meal is accompanied by increased plasma interleukin-6 concentrationsPia Lundman, Susanna Boquist, Ann Samnegård, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada?Nina Johnston, Anna Bornefalk-Hermansson, Karin Schenck-Gustafsson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 18, 2015
Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEARTPeter Damman, Tomas Jernberg, Bertil Lindahl, et al.
European Journal of Preventive Cardiology|April 13, 2012
Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY studyOla Vedin, Emil Hagström, Ralph Stewart, et al.
European Journal of Clinical Investigation|January 3, 2013
Risk prediction in stable angina pectorisThomas Kahan, Lennart Forslund, Claes Held, et al.
American Heart Journal|August 4, 2024
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stentDavid Erlinge, Jonas Andersson, Ole Fröbert, et al.
Upsala Journal of Medical Sciences|August 9, 2018
The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary heart disease-results from the SUPRIM-trialErik M G Olsson, Fredrika Norlund, Ronnie Pingel, et al.
Journal of Medical Internet Research|May 24, 2021
Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-upSophia Monica Humphries, John Wallert, Fredrika Norlund, et al.
Pageof 23

Showing results (51-60 of 227) with videos related to

Sort By:
Pageof 23
European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registryKatarina Mars, John Wallert, Claes Held, et al.
JAMA|April 11, 2023
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical TrialJohan Sundström, Lars Lind, Shamim Nowrouzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 21, 2007
A high-fat meal is accompanied by increased plasma interleukin-6 concentrationsPia Lundman, Susanna Boquist, Ann Samnegård, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada?Nina Johnston, Anna Bornefalk-Hermansson, Karin Schenck-Gustafsson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 18, 2015
Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEARTPeter Damman, Tomas Jernberg, Bertil Lindahl, et al.
European Journal of Preventive Cardiology|April 13, 2012
Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY studyOla Vedin, Emil Hagström, Ralph Stewart, et al.
European Journal of Clinical Investigation|January 3, 2013
Risk prediction in stable angina pectorisThomas Kahan, Lennart Forslund, Claes Held, et al.
American Heart Journal|August 4, 2024
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stentDavid Erlinge, Jonas Andersson, Ole Fröbert, et al.
Upsala Journal of Medical Sciences|August 9, 2018
The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary heart disease-results from the SUPRIM-trialErik M G Olsson, Fredrika Norlund, Ronnie Pingel, et al.
Journal of Medical Internet Research|May 24, 2021
Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-upSophia Monica Humphries, John Wallert, Fredrika Norlund, et al.
Pageof 23